Similar articles

• Nomifensine: diagnostic test in hyperprolactinemic states.

  Müller EE, Genazzani AR, Murru S. Müller EE, et al. J Clin Endocrinol Metab. 1978 Dec;47(6):1352-7. doi: 10.1210/jcem-47-6-1352. J Clin Endocrinol Metab. 1978. PMID: 263356
• Failure of nomifensine administration to discriminate between tumorous and nontumorous hyperprolactinemia.

  Ferrari C, Crosignani PG, Caldara R, Picciotti MC, Malinverni A, Barattini B, Rampini P, Telloli P. Ferrari C, et al. J Clin Endocrinol Metab. 1980 Jan;50(1):23-6. doi: 10.1210/jcem-50-1-23. J Clin Endocrinol Metab. 1980. PMID: 7188615
• Nomifensine in the diagnosis of hyperprolactinemia.

  Gullo D, Carmina E, Mogavero G, Perino A, Venezia R. Gullo D, et al. Acta Eur Fertil. 1981 Dec;12(4):299-306. Acta Eur Fertil. 1981. PMID: 7342611
• [Differential diagnosis of hyperprolactinemia].

  Takeda R, Minagawa F, Nakabayashi H. Takeda R, et al. Nihon Rinsho. 1986 Mar;44(3):671-7. Nihon Rinsho. 1986. PMID: 2874247 Review. Japanese. No abstract available.
• Hyperprolactinaemia; when is a prolactinoma not a prolactinoma?

  [No authors listed] [No authors listed] Lancet. 1987 Oct 31;2(8566):1002-4. Lancet. 1987. PMID: 2889909 Review. No abstract available.